Rakovina Therapeutics Inc.
RKV.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.22M | -1.20M | -1.36M | -1.24M | -2.10M |
| Total Depreciation and Amortization | 97.70K | 96.60K | 98.00K | 98.10K | 96.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 182.80K | 235.70K | 92.30K | 336.80K | 28.10K |
| Change in Net Operating Assets | 168.00K | 359.80K | 792.10K | 54.30K | -218.50K |
| Cash from Operations | -768.00K | -512.60K | -375.50K | -751.60K | -2.19M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 600.00K | -- | 0.00 | 0.00 | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 105.00K | 1.00M | -- | -- | 4.98M |
| Repurchase of Common Stock | -- | -- | -61.00K | -16.70K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 61.00K | -8.70K | -147.30K |
| Cash from Financing | 496.40K | 719.10K | 0.00 | -18.40K | 3.49M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -271.60K | 206.50K | -375.50K | -770.00K | 1.31M |